ACP5 and osteoporosis: To evaluate the response to pharmacologic treatment and to assist the clinical diagnosis of osteoporosis, among the most common markers of bone resorption, tartrate-resistant acid phosphatase 5b (TRACP-5b) and deoxypyridinoline (DPD) have shown great potential [5,7].